TY - T1 - Apolipoprotein C-III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria SN - / UR - http://hdl.handle.net/10138/353308 T3 - A1 - The FinnDiane Study Group; Jansson Sigfrids, Fanny; Stechemesser, Lars; Dahlström, Emma H.; Forsblom, Carol M.; Harjutsalo, Valma; Weitgasser, Raimund; Taskinen, Marja Riitta; Groop, Per Henrik A2 - PB - Y1 - 2022 LA - eng AB - Objectives: We studied apolipoprotein C-III (apoC-III) in relation to diabetic kidney disease (DKD), cardiovascular outcomes, and mortality in type 1 diabetes. Methods: The cohort comprised 3966 participants from the prospective observational Finnish Diabetic Nephropathy Study. Progression of DKD was determined from medical records. A major adverse cardiac event (MACE) was defined as acute myocardial infarction, coronary revascularization, stroke, or cardiovascular mortality through 2017. Cardio... VO - IS - SP - OP - KW - apolipoprotein C-III; cardiovascular disease; diabetes mellitus; diabetic nephropathy; dyslipidemia; mortality; type 1; ENDOTHELIAL DYSFUNCTION; CHOLESTEROL; RISK; NEPHROPATHY; INSULIN; INFLAMMATION; CIII; DYSLIPIDEMIA; ASSOCIATION; CORONARY-ARTERY-DISEASE; 3121 General medicine, internal medicine and other clinical medicine N1 - PP - ER -